Asia Derma, the only Asia Pacific Dermatology and Aesthetic Conference & Exhibition of its kind, has successfully concluded in Singapore. The event took place from 5th to 7th December 2018 at the Suntec Singapore Convention and Exhibition Centre.
Over the course of 3 days, the event received a total 916 visits by conference delegates and trade visitors. Delegates attended talks by over 50 different speakers covering a myriad of topics on the latest treatments and advancements in therapeutic and aesthetic dermatology. The calibre and diversity of speakers, not only from the Asia-Pacific region but across the world, played a vital role in securing delegates to the event. Insightful topics and workshops also enabled attendees to discover and engage with their peers and dermatology specialists. Trade visitors attending the exhibition were given demonstrations of the latest products and devices from over 100 leading, innovative brands in the aesthetic and dermatological industry. With the Republic of Korea as the first Country of Honour for Asia Derma, a special showcase of Korean brands were also exhibited.
Singaporean medical aesthetic device distributor Elogio Asia has also launched EnerJet2.0, which simultaneously delivers kinetic energy and a compound rich in hyaluronic acid (HA) via powerful injection blasts into the deeper layers of the skin.
Alongside the conference, leading pharmaceutical brands ran workshops with top dermatologists, discussing the latest trends and treatments. French dermatology brand ISISPHARMA ran a workshop on breakthroughs in hyperpigmentation treatments, led by Dr Joyce Lim from Singapore, while Spanish dermatology brand Sesderma ran a workshop on microneedling and TRX, led by Dr L Yuan Li from Taiwan and Dr Serrano from Spain.
Delegates and trade visitors attended from Singapore and across the Asia-Pacific region. In this first edition of Asia Derma, Singapore-based delegates and trade visitors represented 46 percent of the audience, followed by 9 percent from Malaysia, 7 percent from Thailand, 6 percent from India, 4 percent each from Indonesia, Vietnam and Republic of Korea and 3 percent from Taiwan. The conference portion of the event was attended by dermatologists from clinics, hospitals and independent practices from across the region. Trade visitors at the exhibition were predominantly from hospitals (32 percent), distributors and agents of dermatology products and devices from the region (22 percent) and owners and buyers from aesthetic clinics (21.4 percent).
Asia Derma 2018 was officially opened by Prof. Fatimah Binte Abdul Lateef, Director, SingHealth Duke-NUS Institute of Medical Simulation (SIMS) and Singapore Member of Parliament, a practising doctor herself. Prof. Fatimah viewed the displays from various brands, and tried her hand at using the latest machines in aesthetic dermatology.
Sharing her sentiments on the event, she elaborates, “Singapore is privileged to host this event. Asia Derma is bringing together practitioners, dermatologists, aesthetic physicians and industry partners from this region and other parts of the world to learn about what’s going on in our field globally, and what are the new developments. Individual countries will have to customise their needs according to the local population but knowing certain things from a global platform like Asia Derma is really important. We have a lot to learn from partners, therefore collaboration and interaction is really important, and is facilitated by such event”.
Anas Al Madani, Vice-Chairman and Group CEO of INDEX Holding said: “We are very delighted with the success of the first edition of Asia Derma that was evident by the number of participating exhibitors, delegates and trade visitors and their positive feedback. We are also proud that we were able to simulate the experience of Dubai Derma in Singapore, and we look forward to further develop the event and consistently attract the region’s most sought-after speakers and leading therapeutic and aesthetic brands in the field of dermatology.”
Additional testimonials from attending brands
“In view that this was the first Asia Derma held in Singapore, the speakers at the scientific conference were reputable and well-respected in the industry.”
- Mr. Jimmy Ang, Managing Director, NeoAsia, Silver Sponsor of Asia Derma.
- Mr. Gabriel Serrano Sanmiguel, Chairman, SesDerma.
To make the conference timings more convenient for practitioners, the next edition will include one weekend. Asia Derma 2019 will return to Singapore from Thursday 31 October – Saturday 2 November 2019.
Osteoarthritis’s First Gene Therapy
Mundipharma has acquired the exclusive rights for Invossa-K in Singapore, Malaysia, the Philippines, Thailand, Vietnam, Indonesia, Myanmar, Australia and New Zealand from Kolon Life Sciences on January 14, 2019. Invossa-K is a non-surgical treatment for osteoarthritis (OA) pain with long-term efficacy that’s been hailed as the world’s first cell-mediated gene therapy for the disease.
Bringing Sight Back
Community outreach programmes carried out by KPJ Pusat Pakar Mata Centre for Sight (KPJ CFS) over a period of several months has helped improve sight for thirty-three individuals in need. In addition to cataract surgeries for twenty-four elderly patients, free prescriptive glasses were handed out to nine children from the Rainbow of Love School. The efforts to bring sight back to the underprivileged was highlighted during KPJ CFS’ Eyesight Day 2018 held at the Tawakal Health Centre, graced by Health Minister, Yang Berhormat, Dr. Lee Boon Chye. Also present were YBhg Dato’ Amirrudin Abdul Satar, President and Managing Director of KPJ Healthcare Bhd, Datin S. Fauziah Jamaluddin, Chairman of KPJ CFS, Tuan Haji Ahmad Nasiruddin Harun, Executive Director of KPJ CFS and Dr. Norazlina Bachik Ng, KPJ CFS Clinical Director. Dr. Norazlina said, “We want to actively educate and empower patients in the fight against vision impairment and avoidable blindness. Many patients tend to delay their treatments due to lack of awareness of symptoms and financial difficulties. Hence, KPJ CFS is able to assist patients in this situation so that they can safeguard their sight to reduce the adverse impact of avoidable blindness.”
The Ckinderella Clinic hosted a tea party titled ‘British High Tea: Party with the Queens’ on October 20, 2018. This fun-filled event hosted all the top finalists from the Mrs Malaysia Global Universe 2019 beauty pageant. All invited guests – who donned glamorous gowns and tiaras – enjoyed a sumptuous high tea while learning tips and tricks on how to properly and flawlessly prepare skin for the stage. Aside from local pageant queens, the event also saw the presence of stunning beauty queens from throughout the region, including Singapore and the Philippines.
On December 19, 2018, Mundipharma submitted an application to the Japanese Pharmaceuticals and Medical Devices Agency to market Remimzolam for general anaesthesia in Japan. Mundipharma prepared the submission after acquiring exclusive rights to develop and market Remimzolam in Japan from specialty German pharmaceuticals company, PAIONAG, in December 2017.
EMSculpt with the PHI Clinic
On October 9, 2018, PHI Clinic Malaysia revealed its latest addition, EMSculpt, to their list of aesthetic services at the launch event at Marini’s on 57. The Emcee of the night, popular TV Host and model, Deborah Priya Henry introduced model, socialite and fitness enthusiast, Datin Sabrina Dani, together with local celebrity Arjalee to share their experience after having completed their EMSculpt sessions.
Lunching with BTL Aesthetics
BTL Aesthetics hosted a media luncheon at the Majestic Hotel on November 13, 2018, to introduce the EMSculpt body contouring system. During the informative session, we learned that EMSculpt is the world’s first non-invasive, pain-free body shaping treatment proven to simultaneously burn fats and build muscle. It uses High-Intensity Focused Electro Magnetic (HIFEM) technology to burn fat and build muscle by 19 percent and 16 percent respectively. In fact, this cutting-edge treatment stimulates an equivalent of 20,000 sit-ups or squats in just 30 minutes. Perfect for those who desire toned abs and lifted behinds, EMSculpt protocols require four half-hour sessions within two weeks for optimal results. It similarly remains a prime treatment for post-natal tummies as it’s proven to reduce rectus diastasis by up to 11 percent. EMSculpt is available at the Retreat Clinic in Setia Alam.